Even low-dose treatment of venlafaxine may provoke recurrence of hypertension in an Asian patient? [2]

General Hospital Psychiatry

Volumn 23, Issue 4, 2001, Pages 232-234

  Bahk, W M ^a   Pae, C U ^a   Chae, J H ^a   Jun, T Y ^a   Kim, K S ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; CYTOCHROME P450 ISOENZYME; NIFEDIPINE; VENLAFAXINE;

ADULT; ANXIETY NEUROSIS; CASE REPORT; HEADACHE; HUMAN; HYPERTENSION; LETTER; MALE; MANIC DEPRESSIVE PSYCHOSIS; NAUSEA; RECURRENT DISEASE; SYSTOLIC BLOOD PRESSURE;

BIPOLAR DISORDER; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHNIC GROUPS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; RECURRENCE; SEROTONIN UPTAKE INHIBITORS;

EID: 0034865994     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(01)00143-8     Document Type: Letter

References (11)

1. Mechanism of action of antidepressant medications
2. Cardiovascular safety in depressed patients; focus on venlafaxine
3. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia
4. Effectiveness of venlafaxine in patients hopitalized for major depression, and melancholia
5. Effects of venlafaxine on blood pressure; a meta-analysis of original data from 3744 depressed patients
6. Antidepressant efficacy, and cardiovascular safety of venlafaxine in young vs old patients with comorbid medical disorder
7. The impact of the CYP2D6, and CYP2C19 genotypes on venlafaxinepharmacokinetics in a Japanese population
8. Asian/non-Asian transcultural tricyclic antidepressant psychopharmacology; a review
9. Predictability of the effects of race or ethnicity on pharmacokinetics of drugs
10. The safety, and tolerability of venlafaxine hydrochloride; analysis of the clinical trials database
11. Venlafaxine-associated blood pressure elevation at low doses; a report of three cases